Skip to content
PeptideGeek

Immune system

Gramicidin, explained simply

The first antibiotic ever mass-produced, discovered in 1939 — still used today in combination antibiotic eye drops and skin preparations.

Well studied in peopleApplied to the skin6 cited sources

Start here

What is Gramicidin?

Gramicidin is an antibiotic peptide discovered in 1939 and the first antibiotic ever produced commercially, before penicillin reached patients. It kills bacteria by punching holes in their membranes, and it is FDA-approved as an ingredient in topical and eye preparations — including Neosporin eye drops for bacterial eye infections. It is for surface use only: at higher levels inside the body it can damage human cells as well.

How it works in your body

Gramicidin is an antimicrobial peptide antibiotic that kills bacteria by punching holes in their cell membranes, used primarily in topical creams and ointments for treating skin infections.

The deeper mechanism, for the curious

Gramicidin is an antibiotic made by the bacterium Bacillus brevis. It is a straight chain of 15 amino acids. It forms voltage-gated ion channels (gramicidin A channels; tiny tunnels that open and close with electric charge) in fatty membranes. Two chain pieces join end to end and coil into a β6.3-helix (a spiral shape) to make each tunnel. These tunnels let small positively charged particles (K+, Na+, H+) cross bacterial membranes. That depolarizes the membrane (wipes out its electric charge) and wrecks the balance of particles that bacteria need to survive. Gramicidin kills Gram-positive bacteria (one major group of bacteria) rapidly, including Bacillus, Corynebacterium, Clostridium, and Staphylococcus species. Very little gets into the bloodstream when it is applied to the skin.

Evidence check

Well studied in people

This has been through large human trials — the strongest kind of evidence. Scientists have tested it on many people and measured what actually happened.

Every numbered marker on this page links to one of the 6 sources at the bottom.

95/100

Bacterial Infection Treatment

Gramicidin kills harmful bacteria on skin and eyes within seconds by punching tiny holes in their outer walls.

92/100

Eye Infection Care

FDA-approved for treating pink eye and other bacterial eye infections when combined with other antibiotics in prescription drops.

88/100

Wound Protection

Found in over-the-counter antibiotic ointments to help prevent infection in minor cuts, scrapes, and burns.

What the research points to

  • Strongly kills Gram-positive bacteria (one major group of bacteria), including Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. It builds tiny channels in the bacterial membrane that let charged particles leak out within seconds, which drains the cell's energy
  • FDA-approved antibiotic for the skin and eyes, with decades of use. It is one ingredient in Neosporin eye solution (gramicidin 0.025 mg/mL plus neomycin and polymyxin B), used for bacterial conjunctivitis (pink eye) and infections on the outside of the eye
  • Historic importance: the first commercially made antibiotic. René Dubos discovered it in 1939, before penicillin was developed for clinical use, and it showed that antibiotics could come from soil microbes
  • Acts extremely fast: gramicidin channels form within milliseconds of entering the membrane. Potassium (K⁺) pours out and sodium (Na⁺) and hydrogen (H⁺) pour in, which collapses the electric charge across the membrane that bacteria need to make energy
  • Its unusual build, with amino acids that alternate between left-handed and right-handed forms (D,L), folds into a spiral (beta-helix) that protein-cutting enzymes struggle to break down, so it keeps working longer where it is applied
  • A key research tool: gramicidin channels are the most studied model for how charged particles cross cell membranes, which has driven major advances in biophysics (the physics of living things) and membrane biology

The most-asked question

How much Gramicidin do I take?

The research-reported range is 0.025 mg/mL, multiple times daily.

  1. Bacterial conjunctivitis, External ocular infection

    Gramicidin 0.025 mg/mL (in neomycin/polymyxin B/gramicidin eye solution); put in 1-2 drops

    • How often
      Every 4 hours (up to 2 drops every hour for severe infection)
    • For how long
      7-10 days
    • How
      Applied to the eye (topical)

    FDA-labeled combination ophthalmic solution for superficial external eye infections; gramicidin is the gram-positive component. Not for injection into the eye 6.

Adjusting your dose

You're at the right dose if…

  • Therapeutic goals being met with minimal side effects
  • Stable and consistent response to treatment
  • Lab values or clinical markers trending in the right direction
  • Good tolerance with manageable or absent side effects

Consider going up if…

  • You've tolerated the current dose for the recommended period without significant side effects
  • Therapeutic goals haven't been met at the current dose level
  • Your healthcare provider recommends dose escalation based on your response
  • Lab work or clinical assessments support a higher dose

Go down if…

  • Side effects are bothersome or impacting daily life despite management strategies
  • You experience any signs of an adverse reaction
  • Lab results indicate the need for dose reduction
  • Your healthcare provider recommends a lower dose based on your response

The ceiling: 0.25 (as determined by your healthcare provider based on individual response and tolerance)

Reconstitution, in plain words

How do I mix Gramicidin?

Peptides usually arrive as a freeze-dried powder in a small vial. “Reconstitution” just means adding sterile water back in so you can measure a dose. Here's how it works for Gramicidin:

What you need

  • Gramicidin in its prescribed form
  • Clean, dry storage container
  • Measuring device if applicable (oral syringe, measuring cup)
  • Calendar or reminder app for dosing schedule

A worked example

Gramicidin comes in pre-measured doses or forms. Follow the exact dosing instructions on your prescription label. No reconstitution or mixing is typically required for this formulation.

Working out your dose

Use Gramicidin exactly as prescribed. Each unit contains the labeled amount. Your healthcare provider will determine the appropriate dose based on your individual needs and response.

Or let the calculator do it

Three quick questions — your vial, your water, your dose — and it tells you the exact syringe mark. “Find dose amount” is preloaded with Gramicidin's recorded schedule.

GramicidinEvery 4 hours (up to 2 drops every hour for severe infection)

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to the unit — like "5 mg". Labeled in IU? Switch the unit to IU.

Type a number to continue.
0

Timing

When do I take Gramicidin?

Best time of day

Apply Gramicidin to clean, dry skin. For best results, use consistently at the same time(s) each day. Evening application is often preferred to allow overnight absorption, unless otherwise directed.

With or without food?

As a topical product, Gramicidin is not affected by food intake. Apply to clean skin and allow adequate absorption time before covering the area.

Taking it with other peptides

Gramicidin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.

The honest list

What side effects could Gramicidin cause?

Common — usually mild

These show up most often. They usually fade as your body adjusts.

  • Eye stinging or burning

    Mild stinging or burning sensation upon instillation of ophthalmic drops, lasting 1-2 minutes. Common with most antibiotic eye drops.

    What to do Self-limiting. Keep eyes closed for 1-2 minutes after application. If persistent, discontinue and consult ophthalmologist.

  • Local skin irritation

    Mild redness or warmth at the topical application site. Common with antibiotic ointments and usually minor.

    What to do Apply thin layer only. If irritation worsens, discontinue and try alternative topical antibiotic.

  • Temporary blurred vision

    Brief visual blurring after application of ophthalmic ointment due to the ointment base coating the eye surface.

    What to do Expected with ointment formulations. Vision clears within 5-10 minutes. Use drops instead of ointment during daytime if vision clarity is important.

  • Skin allergy from contact (contact sensitization)

    Allergic contact dermatitis may develop with prolonged or repeated topical use, manifesting as increased redness, itching, or vesicle formation at the application site.

    What to do Discontinue gramicidin-containing products. Topical corticosteroid for acute dermatitis. Patch testing may identify specific allergen if multiple antibiotic sensitivities.

Less common

Worth knowing about, but most people never see these.

  • New infection from resistant germs taking over (superinfection)

    Overgrowth of resistant bacteria or fungi (particularly Candida) with prolonged topical antibiotic use beyond recommended duration.

    What to do Limit treatment to recommended duration (7-10 days). If superinfection develops, discontinue and treat the new pathogen appropriately.

Serious — stop and get medical help

Rare, but if any of these happen, stop and contact a medical professional.

Week by week

What should I expect from Gramicidin, and when?

  1. Hours 0-24 (first application)

    You might notice
    • Mild stinging or burning at application site (1-2 minutes)
    • Antimicrobial action begins within minutes of application
    • For conjunctivitis: beginning of symptom relief (less discharge, reduced redness)
    • For wounds: antimicrobial barrier established at wound surface
    What's normal
    • Gramicidin channels form within milliseconds — antimicrobial activity is essentially immediate at the site
    • Mild stinging is normal and brief with ophthalmic preparations
    • Significant clinical improvement typically takes 24-48 hours to become apparent
    • Wound applications prevent secondary infection while healing begins
    What's next
    • Continue regular application schedule (3-4x daily ophthalmic, 2-3x daily topical)
    • Clinical improvement expected by day 2-3 for conjunctivitis
    • Maintain wound cleanliness between applications
    • Monitor for any worsening or signs of allergic reaction

  2. Days 2-5 (active treatment)

    You might notice
    • Significant improvement in conjunctivitis symptoms (reduced discharge, decreasing redness, less discomfort)
    • Wound healing progressing with reduced infection signs
    • Possible mild allergic sensitization in susceptible individuals
    • Overall improvement in treated condition
    What's normal
    • Most bacterial conjunctivitis cases respond within 3-5 days of topical antibiotic treatment
    • Superficial wound infections improve within 3-7 days with topical antibiotics
    • Combination preparations (gramicidin + polymyxin B + neomycin) provide broad-spectrum coverage
    • If no improvement by day 3, consider reassessment and alternative therapy
    What's next
    • Complete the full prescribed course (typically 7-10 days)
    • If conjunctivitis resolved by day 5, may discontinue per physician guidance
    • Do not exceed 10 days without medical reassessment
    • Transition to standard wound care once infection is controlled

  3. Days 5-10 (completion)

    You might notice
    • Infection resolved in most cases
    • Eye returns to normal appearance (conjunctivitis)
    • Wound healing well with no signs of infection
    • Treatment course completed
    What's normal
    • Most superficial bacterial infections resolve within 7-10 days of topical treatment
    • No resistance development expected with short topical courses
    • Post-treatment recurrence is uncommon for simple infections
    • Continued wound care (cleaning, protection) after antibiotic completion
    What's next
    • Discontinue gramicidin-containing product at end of treatment course
    • Monitor for any recurrence of symptoms
    • If symptoms persist beyond 10 days, seek medical evaluation for possible resistant organism or alternative diagnosis
    • Resume normal eye care or wound management

How to tell it's actually working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Gramicidin over time
  • Reduction in symptom frequency or severity

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing anything? The usual reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

Is it right for you?

Who should avoid Gramicidin?

Do not use it if…

Be extra careful if…

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Gramicidin use
  • You have any chronic health conditions that require regular monitoring

When to stop

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Gramicidin
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Gramicidin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.

What it mixes badly (and well) with

Medications

  • Avoid
    Systemic administration of any kind — gramicidin is strictly for topical and ophthalmic use due to hemolytic toxicity

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Application to extensive burn wounds or large denuded skin areas — risk of systemic absorption and hemolysis

    Use with caution—discuss with your healthcare provider.

  • Avoid
    Contact lens wear during ophthalmic treatment — remove lenses before applying gramicidin ophthalmic preparations

    Use with caution—discuss with your healthcare provider.

Other peptides

  • OK together
    Polymyxin B (complementary spectrum — gramicidin covers Gram-positives, polymyxin B covers Gram-negatives; this is the basis of Neosporin ophthalmic formulation)

    May be used together under medical guidance.

  • OK together
    Neomycin (aminoglycoside — provides additional Gram-negative and some Gram-positive coverage; standard triple combination in OTC antibiotic ointments)

    May be used together under medical guidance.

  • OK together
    Bacitracin (complementary Gram-positive coverage through peptidoglycan synthesis inhibition — different mechanism than gramicidin's ion channels)

    May be used together under medical guidance.

Supplements

  • OK together
    Multivitamins

    Generally safe to take alongside Gramicidin. Space doses apart if taking oral formulations to ensure optimal absorption.

  • OK together
    Electrolyte supplements

    Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Who it tends to suit

Treating bacterial pink eye (conjunctivitis) and infections on the outside of the eye (FDA-approved)

Gramicidin is particularly well-suited for individuals focused on topical treatment of bacterial conjunctivitis and external eye infections (fda-approved). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 6.

Preventing and treating minor skin infections, small cuts, scrapes, and burns (over-the-counter creams and ointments)

Gramicidin is particularly well-suited for individuals focused on prophylaxis and treatment of superficial skin infections, minor cuts, scrapes, and burns (otc topical preparations). Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Lab research on how charged particles pass through cell membranes (ion channels, measuring electric current through a single channel, and membrane transport)

Gramicidin is particularly well-suited for individuals focused on research into ion channel biophysics, single-channel electrophysiology, and membrane transport mechanisms. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Skin or eye antibiotic combination: gramicidin kills one group of bacteria (Gram-positive) and polymyxin B kills another (Gram-negative)

Gramicidin is particularly well-suited for individuals focused on combination topical antimicrobial therapy providing gram-positive coverage alongside polymyxin b for gram-negatives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach 6.

The safety picture overall

Gramicidin is a cyclic peptide antibiotic derived from Bacillus brevis with a 70+ year track record of topical safety. It functions as a pore-former in bacterial membranes 1 and shows minimal systemic (affecting the whole body) absorption when applied to intact skin or mucous membranes, making it extremely low-toxicity for localized use. The primary safety concern is sensitization reactions in 1-5% of users with prolonged exposure, not organ toxicity. Gramicidin is FDA-approved for topical antibacterial applications and generally well-tolerated across age groups.

Gramicidin safety derives from extensive clinical use since 1940s as a topical antibiotic in wound care and oral preparations, with minimal adverse event reporting. In vitro (in lab dishes, not living bodies) studies confirm rapid bacterial cell death via ion channel disruption 1 without mammalian toxicity at therapeutic concentrations. Contact dermatitis and allergic sensitization are the documented safety signals, not systemic (affecting the whole body) toxicity. FDA oversight and decades of post-marketing surveillance support its continued use in medical devices and antimicrobial formulations.

Keeping it good

How do I store Gramicidin?

Before mixing (powder)

Store Gramicidin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.

After mixing (liquid)

Once reconstituted, Gramicidin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.

Signs it has gone bad

  • Solution appears cloudy, discolored, or contains visible particles (should be clear)
  • Product has been exposed to temperatures outside the recommended storage range
  • Product has been frozen (unless specifically designed for freeze-thaw stability)
  • Expiration date has passed or reconstituted solution has exceeded its use-by date
  • Unusual odor, color change, or visible contamination

Not our opinion — the published record

What the studies actually found about Gramicidin

2005

An asymmetric ion channel derived from gramicidin A. Synthesis, function and NMR structure

FEBS J 2005;272(4):975-86 (PMID 15691331). A lab-made dimer (two-part unit) derived from gramicidin A forms working ion channels (tiny tunnels for charged particles) in flat artificial fat membranes. It shows single-channel currents (electric current through one tunnel) and lets positively charged alkali ions through. Its NMR solution structure (a 3D shape measured in liquid) matches the shape of the active channel in a membrane.

Xie X, Al-Momani L, Reiss P, Griesinger C, Koert U

If this isn't the right fit

What people use instead of Gramicidin

Alternative approaches for immune support

  • Consult your healthcare provider for alternatives to Gramicidin based on your specific needs and medical history

Other immune-support peptides

  • Thymosin Alpha-1
  • LL-37
  • Thymulin

Non-peptide immune support

  • Vitamin D3
  • Zinc supplementation
  • Beta-glucans

Your questions

Gramicidin FAQ

Why can't gramicidin be taken orally or given as an injection?

Gramicidin forms ion channels in any biological membrane it contacts — not just bacterial membranes. When exposed to human red blood cells, gramicidin channels cause rapid K⁺ loss and Na⁺ influx, leading to osmotic swelling and hemolysis (rupture of red blood cells). At systemic (affecting the whole body) concentrations needed for antimicrobial efficacy, massive hemolysis would occur. This hemolytic toxicity makes any systemic route (IV, IM, oral for systemic effect) dangerous. Topical and ophthalmic use is safe because minimal amounts are absorbed into the bloodstream.

Was gramicidin really the first antibiotic?

Gramicidin was the first antimicrobial substance to be commercially manufactured and clinically tested in humans — predating the widespread clinical availability of penicillin. René Dubos discovered it in 1939 at Rockefeller University by isolating antimicrobial compounds from the soil bacterium Brevibacillus brevis. While Alexander Fleming discovered penicillin in 1928, it wasn't until 1941-1942 that penicillin was developed for clinical use. Gramicidin was used topically for wound infections during World War II. Its discovery proved that soil organisms produce antimicrobial substances, directly inspiring Selman Waksman's search that led to streptomycin.

What makes gramicidin's structure so unusual?

Gramicidin A has one of the most unusual structures in biology — its 15 amino acids alternate between D- and L-configurations (D-amino acids are rare in nature). This alternating stereochemistry prevents the peptide from folding into common structures like alpha-helices or beta-sheets. Instead, it forms a unique β⁶·³ helix — a single-stranded helix with 6.3 residues per turn. Two of these helices dimerize head-to-head within the membrane to form a transmembrane channel exactly the right length to span a lipid bilayer.

Is the gramicidin in Neosporin safe?

Yes, gramicidin in topical and ophthalmic preparations like Neosporin is safe when used as directed. The concentrations are low (0.025 mg/mL in ophthalmic solution), systemic (affecting the whole body) absorption through intact skin or eye is minimal, and these products have decades of safe clinical use. The hemolytic toxicity that prevents systemic use only occurs when gramicidin reaches significant concentrations in the bloodstream, which does not happen with normal topical application to small wound areas.

Why is gramicidin so important for scientific research?

Gramicidin channels are the most extensively studied ion channels in all of biophysics. Their small size (just two peptides forming one channel), defined structure, and predictable conductance properties make them ideal model systems for understanding how ions cross biological membranes. Gramicidin channels have been used to develop the theory of ion channel conductance, validate computational molecular dynamics simulations, understand membrane thickness effects on channel function, and develop single-channel electrophysiology techniques. Over 10,000 research papers have been published on gramicidin channels.

Can gramicidin treat MRSA (drug-resistant staph) infections?

Gramicidin has in vitro (in lab dishes, not living bodies) activity against MRSA (methicillin-resistant Staphylococcus aureus) because its ion channel mechanism is independent of the penicillin-binding protein modifications that confer methicillin resistance. However, gramicidin can only be used topically — for superficial MRSA skin infections, topical gramicidin-containing preparations may provide some benefit, but mupirocin or retapamulin are preferred topical agents for MRSA. Serious or deep MRSA infections require systemic (affecting the whole body) antibiotics (vancomycin, daptomycin, linezolid) that gramicidin cannot replace.

6 sources

References

Every numbered marker on this page points to one of these. Same sources, same numbering as the Gramicidin research profile on Peptide Initiative.

  1. An asymmetric ion channel derived from gramicidin A. Synthesis, function and NMR structureXie X, Al-Momani L, Reiss P, Griesinger C, Koert U · 2005
  2. The linear pentadecapeptide gramicidin is assembled by four multimodular nonribosomal peptide synthetases that comprise 16 modules with 56 catalytic domainsKessler N, Schuhmann H, Morneweg S, et al. · 2004
  3. Discovery of gramicidin A analogues with altered activities by multidimensional screening of a one-bead-one-compound libraryTakada Y, Itoh H, Paudel A, et al. · 2020
  4. Synchronization of opening and closing of two gramicidin A channels pulled together by a linker: possible relevance to channel clusteringNovoderezhkin VI, Rokitskaya TI, Kotova EA, et al. · 2023
  5. Machine-Learning Approach to Increase the Potency and Overcome the Hemolytic Toxicity of Gramicidin SKalyvas JT, Wang Y, Horsley JR, et al. · 2025
  6. Neomycin and Polymyxin B Sulfates and Gramicidin Ophthalmic Solution USP Prescribing InformationFDA label (DailyMed) · 2020

Want the deep science?

Read the full Gramicidin research profile

Every claim on this page traces back to the research database behind Peptide Initiative — studies, citations, clinical trial data, and the technical detail we deliberately left out here.

Open the research profile

More immune system guides

This guide is education, not medical advice. Talk to a clinician before taking anything.